✦ LIBER ✦

650 ANTIVIRAL ACTIVITY, COMBINATION AND RESISTANCE OF ACH-1625, A POTENT, CLINICAL STAGE HCV NS3 PROTEASE INHIBITOR

✍ Scribed by M. Huang; J. Fabrycki; D. Patel; S. Podos; G. Yang; Y. Zhao; C.W. Marlor; K. Stauber; A. Agarwal; X. Wang; M. Deshpande; A. Phadke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

770 CHARACTERIZATION OF THE HEPATOSELECT

✍ K. Stauber; C.W. Marlor; G. Mushtaq; V. Gadhachanda; G. Pais; A. Hashimoto; A. P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

[791] HCV ANTIVIRAL ACTIVITY AND RESISTA

✍ D.B. Olsen; S.S. Carroll; L. Handt; S. Ludmerer; D. Graham; C. Fandozzi; J. DeLu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

876 ACH-3102, A SECOND GENERATION NS5A I

✍ Muir, A.; Hill, J.; Lawitz, E.; Marbury, T.; Robarge, L.; Robison, H.; Hui, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Characterization of vaniprevir, a hepati

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

1248 GENOTYPIC AND PHENOTYPIC CHARACTERI

✍ Wong, K.A.; Bae, A.; Ku, K.; Dvory-Sobol, H.; Waters, J.; Miller, M.D.; Mo, H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

938 DISCOVERY OF POTENT, BIOAVAILABLE HC

✍ B. Buckman; K. Kossen; D. Ruhrmund; R. Rajagopalan; S. Stevens; L. Hooi; L. Snar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB